A New hybrid radiotherapy technique for non-small cell lung cancer: Is more effective for functional lung sparing

被引:0
作者
Chen, C. [1 ]
Chen, G. [1 ]
Fang, R. [1 ]
Xu, Y. [1 ]
Liu, H. [1 ]
Liao, Z. [1 ]
机构
[1] Wuhan Univ, Zhongnan Hosp, Hubei Canc Clin Study Ctr, Hubei Key Lab Tumor Biol Behav,Dept Radiat & Med O, Wuhan 430071, Hubei, Peoples R China
来源
INTERNATIONAL JOURNAL OF RADIATION RESEARCH | 2024年 / 22卷 / 03期
关键词
carcinoma; three dimensional conformal; radiotherapy; intensity-modulated; MODULATED RADIATION-THERAPY; ARC THERAPY; IMAGE REGISTRATION; VENTILATION; PNEUMONITIS; IMRT; VMAT; REDUCTION;
D O I
10.61186/ijrr.22.3.609
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Background: The Conventional thoracic radiotherapy planning ignores regional pulmonary function changes. This study aimed to evaluate the beneficial effect of a new hybrid three-dimensional conformal radiation therapy (3DCRT)/intensitymodulated radiation therapy (IMRT) technique. Materials and Methods: Thirty patients with non-small cell lung cancer were included in this study. Four protocols were designed for each patient: anatomical IMRT (A-IMRT, based on the total lung), functional IMRT (F-IMRT), pure IMRT (O-IMRT) plan, and hybrid 3DCRT/IMRT plan (H3DCRT/IMRT), which were based on the functional lung. The opposing pair of fields in the O-IMRT and H-3DCRT/IMRT protocols provide 2/9 and 1/2 of radiation dose, respectively. The planning target volume coverage, dose in both total and functional lungs, maximum spinal cord dose, mean esophagus dose, mean heart dose, homogeneity index (HI), conformity index (CI), and treatment monitor units (MUs) were compared in this study. Results: The V5, V20, and mean dose (Dmean) of the both total and functional lungs in the H-3DCRT/IMRT protocol were the lowest among the four treatment regimes. For D2, D98, HI, and CI, the A-IMRT protocol was superior to the H-3DCRT/IMRT protocol. Compared with the A-IMRT protocol, the F-IMRT protocol achieved significantly lower V5, V20, and Dmean for functional lungs, but showed worse HI, CI, and maximum dose of spinal cord. The H-3DCRT/IMAT protocol significantly reduced the maximum spinal cord dose and MUs. Conclusions: The H-3DCRT/IMAT plan based on functional lung images appeared to be better than conventional F-IMRT in preserving functional lung without compromising on HI and CI in NSCLC patients.
引用
收藏
页码:609 / 616
页数:8
相关论文
共 50 条
  • [41] Prior or concurrent radiotherapy and nivolumab immunotherapy in non-small cell lung cancer
    Ratnayake, Gishan
    Shanker, Mihir
    Roberts, Kate
    Mason, Robert
    Hughes, Brett G. M.
    Lwin, Zarnie
    Jain, Vikram
    O'Byrne, Kenneth
    Lehman, Margot
    Chua, Benjamin
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2020, 16 (01) : 56 - 62
  • [42] A critical review of recent developments in radiotherapy for non-small cell lung cancer
    Sarah Baker
    Max Dahele
    Frank J. Lagerwaard
    Suresh Senan
    Radiation Oncology, 11
  • [43] Stereotactic body radiotherapy for stage I non-small cell lung cancer
    Martel-Lafay, I.
    ONCOLOGIE, 2012, 14 (05) : 282 - 288
  • [44] Adjuvant chemotherapy and radiotherapy in the treatment of non-small cell lung cancer (NSCLC)
    Zaric, Bojan
    Stojsic, Vladimir
    Tepavac, Aleksandar
    Sarcev, Tatjana
    Zarogoulidis, Paul
    Darwiche, Kaid
    Tsakiridis, Kosmas
    Karapantzos, Ilias
    Kesisis, Georgios
    Kougioumtzi, Ioanna
    Katsikogiannis, Nikolaos
    Machairiotis, Nikolaos
    Stylianaki, Aikaterini
    Foroulis, Christophoros N.
    Zarogoulidis, Konstantinos
    Perin, Branislav
    JOURNAL OF THORACIC DISEASE, 2013, 5 : S371 - S377
  • [45] Targeted therapy combined with thoracic radiotherapy for non-small cell lung cancer
    Yavas, Guler
    Yavas, Cagdas
    JOURNAL OF RADIATION ONCOLOGY, 2019, 8 (01) : 1 - 12
  • [46] Dose and fractionation concepts in the primary radiotherapy of non-small cell lung cancer
    Baumann, M
    Appold, S
    Petersen, C
    Zips, D
    Herrmann, T
    LUNG CANCER, 2001, 33 : S35 - S45
  • [47] A critical review of recent developments in radiotherapy for non-small cell lung cancer
    Baker, Sarah
    Dahele, Max
    Lagerwaard, Frank J.
    Senan, Suresh
    RADIATION ONCOLOGY, 2016, 11
  • [48] Radiotherapy and Immunotherapy Combinations in Non-small Cell Lung Cancer: A Promising Future?
    Hanna, G. G.
    Illidge, T.
    CLINICAL ONCOLOGY, 2016, 28 (11) : 726 - 731
  • [49] Radiotherapy in Italy for non-small cell lung cancer: patterns of care survey
    Ramella, Sara
    Maranzano, Ernesto
    Frata, Paolo
    Mantovani, Cristina
    Lazzari, Grazia
    Menichelli, Claudia
    Navarria, Piera
    Pergolizzi, Stefano
    Salvi, Fabrizio
    TUMORI JOURNAL, 2012, 98 (01): : 66 - 78
  • [50] Machine learning in non-small cell lung cancer radiotherapy: A bibliometric analysis
    Zhang, Jiaming
    Zhu, Huijun
    Wang, Jue
    Chen, Yulu
    Li, Yihe
    Chen, Xinyu
    Chen, Menghua
    Cai, Zhengwen
    Liu, Wenqi
    FRONTIERS IN ONCOLOGY, 2023, 13